SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014414
Filing Date
2023-08-10
Accepted
2023-08-10 08:18:30
Documents
75
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mtem-20230630x10q.htm   iXBRL 10-Q 1889020
2 EX-31.1 mtem-20230630xex31d1.htm EX-31.1 9802
3 EX-31.2 mtem-20230630xex31d2.htm EX-31.2 9776
4 EX-32.1 mtem-20230630xex32d1.htm EX-32.1 6881
5 GRAPHIC mtem-20230630x10q007.jpg GRAPHIC 58892
  Complete submission text file 0001558370-23-014414.txt   7488320

Data Files

Seq Description Document Type Size
6 EX-101.SCH mtem-20230630.xsd EX-101.SCH 55163
7 EX-101.CAL mtem-20230630_cal.xml EX-101.CAL 53790
8 EX-101.DEF mtem-20230630_def.xml EX-101.DEF 197724
9 EX-101.LAB mtem-20230630_lab.xml EX-101.LAB 490417
10 EX-101.PRE mtem-20230630_pre.xml EX-101.PRE 362788
69 EXTRACTED XBRL INSTANCE DOCUMENT mtem-20230630x10q_htm.xml XML 1154505
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 231157286
SIC: 2834 Pharmaceutical Preparations